Pharmaceutical Industry in Spain: Market Research Reports, Statistics and Analysis

Company Report: Pathology In Europe For Year 2013

... For patients in spain. Epidermolysis bullosa , scl Scleroderma, cf cystic fibrosis, hemo Prader-willi syndrome, xfr Fragile x syndrome. Direct non ...

Company Report: Diabete In Spain For Year 2013

Company Report: Pathology In Spain For Year 2012

... Ace inhibitors and beta-blockers remain the main stay in the treatment of heart failure, the results of the shift trial demonstrate that a reduction in heart rate when elevated with ivabradine improves ...

Clinical Trial Market In Spain

... And human services j:\ Guidanc\6359occ.Doc observational studies are not Clinical investigations; No permission required from the fda1; fda S ind regulations only apply to Clinical investigations 2 ...

The Spanish Clinical Trial Sector Brief

... An organized system that Uses observational study methods to collect uniform data (clinical and other) Evaluates specified outcomes for a population defined by a particular disease, condition ...

The Spanish Drug Industry

... Reports of ae of interest/ estimated total number of prescriptions Reporting rate is compared to the reporting rate of comparator drugs with similar indication If reporting rate of drug of interest ...

Heart Disease Industry Statistics In Spain And Germany

Mental Health Market In The United States And Spain

... Treatment. To increase access to mental health services for young people, we should: Provide Mental health first aid Training to help teachers and staff recognize signs of mental illness in young ...

Diabete Market In The United States And Spain

... To prevent or delay the onset and progression of diabetes and its complications. gestational diabetes mellitus (gdm) Diagnosed during pregnancy Affects at least 7% and possibly as many as 18% of u ...